Related Experiment Video
Updated: Dec 27, 2025

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction
Julia Kodysh1, Alex Rubinsteyn2
1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. julia@openvax.org.
Abstract:
OpenVax is a computational workflow for identifying somatic variants, predicting neoantigens, and selecting the contents of personalized cancer vaccines. It is a Dockerized end-to-end pipeline that takes as input raw tumor/normal sequencing data. It is currently used in three clinical trials (NCT02721043, NCT03223103, and NCT03359239). In this chapter, we describe how to install and use OpenVax, as well as how to interpret the generated results.
Insights
OpenVax is a computational workflow for identifying cancer mutations and predicting neoantigens for personalized cancer vaccines. This pipeline analyzes tumor/normal sequencing data and is used in ongoing clinical trials.
Area of Science:
- Computational biology
- Immunogenomics
- Cancer immunotherapy
Background:
- Personalized cancer vaccines require accurate identification of tumor-specific mutations and neoantigens.
- Computational tools are essential for analyzing complex genomic data in cancer research.
Purpose of the Study:
- To describe the installation and usage of OpenVax, a computational workflow for personalized cancer vaccine development.
- To guide users in interpreting the results generated by the OpenVax pipeline.
Main Methods:
- OpenVax is a Dockerized, end-to-end computational pipeline.
- It processes raw tumor and normal sequencing data.
- The workflow includes somatic variant identification and neoantigen prediction.
Main Results:
- OpenVax successfully identifies somatic variants and predicts neoantigens.
- The workflow is currently implemented in three active clinical trials.
- Detailed instructions for installation, usage, and result interpretation are provided.
Conclusions:
- OpenVax provides a robust computational framework for personalized cancer vaccine design.
- The workflow facilitates the integration of genomic data into clinical applications for cancer immunotherapy.
- The described methods enable researchers and clinicians to utilize OpenVax effectively.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Tumor Immunotherapy
Cancer Survival Analysis
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

